Lbp Am Sa Boosts ResMed Stake by 364%

Investment firm increases holdings in medical equipment provider during Q4

Apr. 18, 2026 at 7:59am

Got story updates? Submit your updates here. ›

An extreme close-up of complex medical machinery and equipment in shades of silver, steel, and chrome, conceptually representing the advanced engineering behind ResMed's respiratory care devices.Lbp Am Sa's significant increase in its ResMed holdings suggests the firm sees strong growth potential in the medical equipment provider's advanced respiratory care technology.San Diego Today

Lbp Am Sa, a large investment firm, significantly increased its stake in ResMed Inc. (NYSE: RMD) by 364.1% during the fourth quarter, according to a recent SEC filing. The firm now owns 23,125 shares of the medical equipment provider's stock, valued at $5.57 million.

Why it matters

ResMed is a leading global provider of sleep apnea and respiratory care devices, and its stock performance is closely watched by investors in the medical technology sector. Lbp Am Sa's substantial increase in its ResMed holdings suggests the firm sees strong growth potential for the company.

The details

According to the SEC filing, Lbp Am Sa acquired an additional 18,142 shares of ResMed during the fourth quarter, bringing its total holdings to 23,125 shares. This represents a 364.1% increase in the firm's stake in the medical equipment provider. ResMed's stock price has fluctuated in recent months, with the company reporting mixed financial results.

  • Lbp Am Sa increased its ResMed holdings during the fourth quarter of 2025.
  • The SEC filing disclosing the stake increase was made on April 18, 2026.

The players

Lbp Am Sa

A large investment firm that significantly increased its stake in ResMed Inc. during the fourth quarter.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

Lbp Am Sa's substantial increase in its ResMed holdings suggests the firm sees strong growth potential for the medical equipment provider, which is a leader in sleep apnea and respiratory care devices.